{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        991, 
        997
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        761, 
        784
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        814, 
        841
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        614, 
        643
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2302, 
        2328
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        981, 
        990
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        959, 
        980
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2330, 
        2332
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 7^9999^MOH||CCO-OCR|20160501033350|DA1C0DDA7AC27447A74D8BE007BF6E6AD95E9ABE|ORU^R01|99999999999999999999|P|2.5|||\nPID|1||9999999^^^^CMR^&9999&MOH~9999999^^^^RMR^&9999&MOH~9999999^^^^MRN^&9999&MOH~9999999999&B&ON^^^^JHN|9999^9999999|XXXXXX^XXXXXXX^XXXXXXX^^XX.^||99999999|F|XXXXXX^XXXXXXX^^^^||999-99 XXXXXX XXXXXX^^XXXXXXX^XX^X9X9X9^999||(999)999-999|||||||||||||||||N||\nOBR|1||TS16-3581|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201603301456|||59520^XXXX^XXXXXXX^^^^||||201603301457||99999^XXXX^XXXXXXX^^^^||||||201604130803|||C|||||||99999^XXXXX^XXXXXXX^^^^||\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen consists of 7 pieces of tissue each measuring 0.2 cm. The specimen is submitted in toto in 2 blocks.\n\n\nPath report.relevant Hx\n\nEndobronchial obstruction\n\n\nPath report.final diagnosis\n\n**PRELIMINARY DIAGNOSIS ONLY - FINAL DIAGNOSIS PENDING EXTERNAL CONSULTATION**\nRIGHT LOWER LOBE BRONCHUS, BIOPSY:\n- POORLY DIFFERENTIATED MALIGNANT TUMOUR\n- MAY REPRESENT SARCOMATOID CARCINOMA, SARCOMA CANNOT BE EXCLUDED\n- SEE COMMENT\nCOMMENT:\nThe findings are of a poorly differentiated malignant tumour. Tumour cells are positive for vimentin and show very focal, very faint staining for AE1AE3 and rare cells positive for EMA. There is a faint blush of CD56 positivity. CK8/18, CK7, CK5/6, S100, CD45, P40, synaptophysin, chromogranin, TTF-1, and CEA are negative.\nThe findings are not specific for a particular tumour subtype. It is possible that this represents a sarcomatoid carcinoma. A sarcoma cannot be excluded. This case is being sent to the Soft Tissue group at Mt. Sinai HOSPITAL for an opinion. An addendum will be issued.\nThis case was reviewed at intradepartmental rounds.\n\n\nPath Report.addendum spec\n\nThe consultation report has been received from Dr. Brendan Mullen at Mt. Sinai hospital. The diagnosis and comment are transcribed below. A copy of the full report is kept on file in the pathology department.\nLUNG (BIOPSY RIGHT LOWER LOBE BRONCHUS):\n- HIGH GRADE NEUROENDOCRINE CARCINOMA, FAVOR SMALL CELL NEUROENDOCRINE CARCINOMA\nCOMMENT:\nThe results are most consistent with a high grade neuroendocrine carcinoma (ie large cell neuroendocrine carcinoma or small cell neuroendocrine carcinoma), favor small cell neuroendocrine carcinoma.\n\n\nPath report.site of origin\n\nA: Bronchial, bronchus RLL biopsy\n\n\n"
}